Vemurafenib (VM) in non-melanoma V600 and non-V600 BRAF mutated cancers: first results of the ACSE trial

Authors :: Frederique Nowak
Xavier Troussard
J. Mazieres
J.-Y. Blay
Ivan Bièche
Marta Jimenez
Gilbert Ferretti
Aude Flechon
David Malka
Fabrice Barlesi
D. Perol
Jean Trédaniel
G. Quere
Bertrand Arnulf
Sophie Leboulleux
D. Moro-Sibilot
Claude Linassier
N. Hoog-Labouret
I.L. Ray-Coquard
Agnes Buzyn
Source :: Annals of Oncology. 27:vi16
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 0301 basic medicine
03 medical and health sciences
030104 developmental biology
Oncology
business.industry
Cancer research
Medicine
Hematology
business
Vemurafenib
medicine.drug
Non melanoma

Full Text Access

Tools